Clinical data | |
---|---|
Other names | RU-28318; 17α-Hydroxy-3-oxo-7α-propylpregn-4-ene-21-carboxylic acid monopotassium salt |
Drug class | Antimineralocorticoid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C25H37KO4 |
Molar mass | 440.665 g·mol−1 |
3D model (JSmol) | |
| |
|
Oxprenoate potassium (developmental code name RU-28318) is a synthetic steroidal antimineralocorticoid which was never marketed.[1] The affinities of oxprenoate potassium for the steroid hormone receptors have been reported.[2]
See also
[edit]References
[edit]- ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 922–. ISBN 978-1-4757-2085-3.
- ^ Raynaud JP, Fortin M, Hunt P, Ojasoo T, Doré JC, Surcouf E, Mornon JP, et al. (Fondation Princesse Liliane) (1986). "Approaches to drug development using receptors". In Gotto AM, O'Malley BW (eds.). The Role of Receptors in Biology and Medicine: Proceedings of the Ninth Argenteuil Symposium. Raven Press. pp. 65–77. ISBN 978-0-88167-161-2.